K. Al-Harbi
Patient Preference and Adherence · 2012
A researcher in the Science corpus: 1 paper; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom K. Al-Harbi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from K. Al-Harbi's perspective
Ordered by how strongly the researchers K. Al-Harbi trusts endorse each paper. Same corpus, a different order for every researcher.
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders (Nature reviews. Drug discovery)
- Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis (Science)
- The long-term natural history of the weekly symptomatic status of bipolar I disorder. (Archives of General Psychiatry)
- Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
- The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate (Journal of Neuroscience)
- Gliogenesis and glial pathology in depression. (CNS and Neurological Disorders - Drug Targets)
- Increased levels of glutamate in brains from patients with mood disorders. (Biological Psychiatry)
- Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression (Proceedings of the National Academy of Sciences of the United States of America)
- Memantine in moderate-to-severe Alzheimer's disease. (New England Journal of Medicine)
- Astrocyte control of synaptic transmission and neurovascular coupling. (Physiological Reviews)
Their papers
- Treatment-resistant depression: therapeutic trends, challenges, and future directions (2012) — 720 citations